Wouter W. Latour
Keine laufenden Positionen mehr
Karriereverlauf von Wouter W. Latour
Ehemalige bekannte Positionen von Wouter W. Latour
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Trinity Biosystems, Inc.
Trinity Biosystems, Inc. Pharmaceuticals: MajorHealth Technology Trinity Biosystems, Inc. develops and formulates orally delivered bio-therapeutic macromolecules. It offers TriPex system, an approach to macromolecule delivery that works cooperatively with the natural physiology of the body. The system utilizes a specific and natural biological transport mechanism: a receptor-mediated transcellular transport pathway that allows passage through the mucosal epithelium and delivery of the therapeutic payload into the blood. The company was founded by Randall J. Mrsny on July 19, 2002 and is headquartered in Menlo Park, CA. | Vorstandsvorsitzender | 01.01.2005 | 01.05.2009 |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | 01.01.1998 | 01.01.2000 |
Smithkline Beecham Plc
Smithkline Beecham Plc Pharmaceuticals: OtherHealth Technology Smithkline Beecham Plc develops and manufactures pharmaceutical products. The company markets pharmaceuticals for human and animal healthcare consumption, vaccines, over the counter medicines, health related consumer products, clinical laboratory testing services, disease management and pharmaceutical benefit management. It is headquartered in Brentford, UK. | Corporate Officer/Principal | 01.01.1994 | 01.01.1998 |
VAXART, INC. | Direktor/Vorstandsmitglied | 01.06.2011 | 30.11.2019 |
Vorstandsvorsitzender | 01.06.2011 | 14.06.2020 | |
Vorsitzender | 30.11.2019 | - | |
Geschäftsführer | 01.06.2011 | 01.09.2011 | |
Finanzdirektor/CFO | 01.01.2019 | 14.06.2020 | |
Präsident | 01.06.2011 | 14.06.2020 | |
NOVAVAX, INC. | Corporate Officer/Principal | - | - |
Vaxart, Inc. /Old/
Vaxart, Inc. /Old/ BiotechnologyHealth Technology Vaxart, Inc. develops technology for oral vaccination against infectious agents. Its products in pipeline include H1N1 seasonal influenza vaccine and oral H5N1 avian influenza vaccine. The firm develops oral recombinant vaccines based on its proprietary oral vaccine delivery platform. The company was founded by Sean N. Tucker in 2004 and is headquartered in San Francisco, CA. | Direktor/Vorstandsmitglied | 01.06.2011 | - |
Vorstandsvorsitzender | 01.06.2011 | - |
Ausbildung von Wouter W. Latour
University of Amsterdam | Doctorate Degree |
Stanford University | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 7 |
Niederlande | 2 |
Vereinigtes Königreich | 2 |
Operativ
Chief Executive Officer | 3 |
Corporate Officer/Principal | 3 |
Director/Board Member | 2 |
Sektoral
Health Technology | 7 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
NOVAVAX, INC. | Health Technology |
VAXART, INC. | Health Technology |
Private Unternehmen | 4 |
---|---|
Trinity Biosystems, Inc.
Trinity Biosystems, Inc. Pharmaceuticals: MajorHealth Technology Trinity Biosystems, Inc. develops and formulates orally delivered bio-therapeutic macromolecules. It offers TriPex system, an approach to macromolecule delivery that works cooperatively with the natural physiology of the body. The system utilizes a specific and natural biological transport mechanism: a receptor-mediated transcellular transport pathway that allows passage through the mucosal epithelium and delivery of the therapeutic payload into the blood. The company was founded by Randall J. Mrsny on July 19, 2002 and is headquartered in Menlo Park, CA. | Health Technology |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
Smithkline Beecham Plc
Smithkline Beecham Plc Pharmaceuticals: OtherHealth Technology Smithkline Beecham Plc develops and manufactures pharmaceutical products. The company markets pharmaceuticals for human and animal healthcare consumption, vaccines, over the counter medicines, health related consumer products, clinical laboratory testing services, disease management and pharmaceutical benefit management. It is headquartered in Brentford, UK. | Health Technology |
Vaxart, Inc. /Old/
Vaxart, Inc. /Old/ BiotechnologyHealth Technology Vaxart, Inc. develops technology for oral vaccination against infectious agents. Its products in pipeline include H1N1 seasonal influenza vaccine and oral H5N1 avian influenza vaccine. The firm develops oral recombinant vaccines based on its proprietary oral vaccine delivery platform. The company was founded by Sean N. Tucker in 2004 and is headquartered in San Francisco, CA. | Health Technology |
- Börse
- Insiders
- Wouter W. Latour
- Erfahrung